FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

104 letters match. Newest first.

  1. 100Misterios, LDA

    Portuguese canner 100Misterios' seafood safety plans and sardine canning process controls fall short, FDA says

    High risk
  2. Waiakea Bottling Inc.

    FDA warned Waiakea Bottling that ineffective water treatment and weak process controls led to microbial contamination in bottled water.

    High risk
  3. AnuMed International, LLC

    FDA warned AnuMed International about unapproved drugs, misleading FDA claims, and manufacturing quality failures.

    High risk
  4. EyePoint Pharmaceuticals, Inc.

    FDA cited EyePoint Pharmaceuticals in Watertown, MA for manufacturing-quality violations affecting its YUTIQ eye implant, including inadequate investigations and process controls.

    High risk
  5. Berkeley Biologics, LLC, previously operating as Elutia, Inc. – Orthobiologics Business Unit, formerly Aziyo Biologics, Inc.

    FDA says Berkeley Biologics' viable bone matrix products are unapproved drugs, with donor screening failures tied to tuberculosis infections.

    High risk
  6. YangZhou SuXiang Medical Instrument Co., Ltd.

    FDA warns YangZhou SuXiang Medical Instrument over manufacturing quality failures and import alert for OTC drugs.

    High risk
  7. Max Chemical Inc.

    FDA warned Max Chemical Inc. in San Juan, Puerto Rico, that its OTC drug manufacturing violated CGMP, making its drugs adulterated.

    High risk
  8. ARG Laboratories, Inc.

    FDA found ARG Laboratories released failing over-the-counter drug lots, lacked manufacturing controls, and marketed two unapproved pain creams.

    High risk
  9. Art of Beauty Company, Inc.

    FDA warned Art of Beauty over manufacturing-rule violations in OTC hand sanitizer, including missing component and finished-product testing.

    High risk
  10. Tamara Fruit CJSC

    FDA warns Tamara Fruit CJSC that its juice nectars and acidified Imam-Bayaldi are adulterated after inspection found HACCP and recordkeeping failures.

    High risk
  11. Aqualex Co., Ltd.

    Aqualex, a Korean contract manufacturer, was cited for manufacturing failures and an unapproved OTC sunscreen with misleading labeling.

    High risk
  12. Safari Stem Cell, LLC

    FDA warned Safari Stem Cell for selling unapproved stem cell animal drugs made without required CGMP controls, including sterility testing.

    High risk
  13. Swity d.o.o.

    FDA warned Swity d.o.o. over acidified yellow pepper fillets made outside its filed process, with inadequate corrective response.

    High risk
  14. Hacienda Mexican Foods, LLC

    FDA warns Hacienda Mexican Foods of Salmonella risk and missing controls in ready-to-eat tortillas.

    High risk
  15. Hunan Gagazui Food Co., Ltd.

    Hunan Gagazui Food Co., Ltd. processed U.S.-bound low-acid canned surimi soybean snacks outside its filed process and without required retort controls.

    High risk
  16. C&T Dream Co., Ltd.

    C&T Dream failed CGMP (current good manufacturing practice) for its over-the-counter Dry Skin Healing Ointment, including identity testing and process validation.

    High risk
  17. Master Paints & Chemicals Corp.

    FDA warned Master Paints & Chemicals Corp. over inadequate testing and quality oversight for OTC drugs including hand sanitizer.

    High risk
  18. Kitchen Garden Foods, LTD

    FDA warned Kitchen Garden Foods that its exported acidified chutneys lacked filed processes and required controls.

    Medium
  19. Bodywell Natural Skin Care Inc.

    FDA warned Bodywell Natural Skin Care that its OTC hand sanitizer and Dermalere creams were adulterated due to CGMP failures and unapproved drug claims.

    High risk
  20. Thai Nakorn Patana Co., Ltd.

    FDA warns Thai Nakorn Patana over manufacturing quality violations, including missing identity and strength testing before release of OTC drugs.

    High risk
  21. Colgin, Inc.

    FDA warned Colgin that its OTC drug ChigaRid External Analgesic violated manufacturing quality rules, including expired ingredients and missing tests.

    High risk
  22. QuVa Pharma, Inc.

    FDA warned QuVa Pharma, a sterile drug outsourcing facility in Bloomsbury, NJ, of mold in its cleanest filling area and other CGMP failures.

    High risk
  23. ReConserve Inc.

    FDA warned ReConserve Inc. that animal-food ingredients stored outdoors uncovered were contaminated and its preventive controls were inadequate.

    High risk
  24. MiMedx Group, Inc.

    FDA cites MiMedx for marketing placental product AXIOFILL without BLA or IND and for CGMP failures.

    High risk
  25. Deymed Diagnostic s.r.o.

    Deymed Diagnostic s.r.o.'s BrainFeedback Pro, TruScan LT, and DuoMAG NL devices had quality system violations in design, complaints, production, and records.

    Medium
  26. Dextrum Laboratories Inc.

    FDA found Dextrum Laboratories, an over-the-counter drug contract manufacturer, failed identity testing, toxic glycol checks, water monitoring, and process validation.

    High risk
  27. Colonial Dames Company, Ltd

    FDA warns Colonial Dames of manufacturing violations and unapproved acne drug claims for Oxygenetix.

    High risk
  28. Brenntag Great Lakes, LLC

    Brenntag Great Lakes failed to prevent cross-contamination of OTC hand sanitizer made on equipment shared with industrial chemicals.

    High risk
  29. Lex Inc.

    FDA warns Lex Inc. of Medley, Florida, that its over-the-counter drugs are adulterated because manufacturing rules were not met, including missing toxic-ingredient testing.

    High risk
  30. Reckitt/Mead Johnson Nutrition

    FDA warned Reckitt/Mead Johnson over Cronobacter contamination and inadequate process controls at two powdered infant formula plants.

    High risk
  31. ByHeart, Inc.

    FDA warns ByHeart that Cronobacter contamination in infant formula and weak investigations led to release of adulterated powdered formula.

    High risk
  32. Perrigo Wisconsin, LLC

    FDA found Cronobacter in Perrigo infant formula and facility; company recalled some Gerber Good Start Soothe Pro.

    High risk
  33. STC India Private Limited

    FDA warned STC India over insanitary conditions and missing Salmonella controls for ready-to-eat mukhwas.

    High risk
  34. Baxter Healthcare Corporation

    FDA warned Baxter over CGMP violations at its India plant, including inadequate endotoxin and visual inspection investigations for sterile injectables.

    High risk
  35. RemedyRepack, Inc.

    RemedyRepack, a drug repackager in Indiana, Pennsylvania, failed CGMP, including cleaning and beta-lactam cross-contamination controls.

    High risk
  36. North American Diagnostics, LLC

    FDA warns North American Diagnostics over unapproved COVID-19 antigen tests and quality system failures.

    High risk
  37. Old Europe Cheese, Inc.

    Old Europe Cheese's ready-to-eat Brie and Camembert were tied to a six-state Listeria outbreak and made under insanitary conditions.

    High risk
  38. Cosmetic Science Laboratories LLC

    FDA warned Cosmetic Science Laboratories about OTC sunscreen drugs made without required manufacturing controls.

    High risk
  39. Formology Lab Inc.

    FDA warned Formology Lab Inc. about manufacturing rule violations for drugs, including untested ingredients and unvalidated sunscreen processes.

    High risk
  40. Profounda, Inc.

    FDA warns Profounda about manufacturing quality failures for over-the-counter drugs, including process validation, stability, water system, and glycerin testing.

    High risk
  41. B & J Group

    B & J Group, a Morrisville, PA contract filler of OTC hand sanitizer, was cited by FDA for skipping finished-product and ingredient testing.

    High risk
  42. Gascó Industrial Corporation

    FDA cites Gascó Industrial for CGMP violations in OTC hand soap, antiseptics, and hand sanitizer, including shared equipment with industrial products.

    High risk
  43. Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil

    FDA warned Delta Kozmetik that its OTC drug products were adulterated due to CGMP violations.

    High risk
  44. Shuzy Rock Inc.

    FDA warns Shuzy Rock Inc. of adulterated hand sanitizers made under insanitary conditions and found below labeled alcohol strength.

    High risk
  45. System Kosmetik Produktionsgesellschaft fur kosmetische Gmbh

    German OTC drug maker System Kosmetik was cited for manufacturing quality violations, including missing process and cleaning validation.

    High risk
  46. Bioiberica, SAU

    FDA warned Bioiberica over unvalidated rework and missing stability testing of API batches at its Spain plant.

    High risk
  47. Colorful Products Corporation

    FDA warned Colorful Products Corporation about serious current good manufacturing practice (CGMP) failures for its over-the-counter topical drugs and hand sanitizers.

    High risk
  48. Froggy’s Fog LLC

    FDA warns Froggy’s Fog that its OTC hand sanitizer was made under inadequate CGMP and mislabeled for alcohol strength.

    High risk
  49. The W.S. Badger Company, Inc.

    FDA warned W.S. Badger over repeat manufacturing-quality failures in OTC drug products, including sunscreen process, cleaning, test-method, and OOS investigation problems.

    High risk
  50. Dr Retter Ec Wladyslaw Retter

    FDA warns Dr Retter Ec Wladyslaw Retter over manufacturing failures for homeopathic drug cream.

    High risk